T1	chemical 19 26	antigen
T2	chemical 48 55	antigen
T3	disease_or_phenotypic_feature 76 87	lung cancer
T4	chemical 126 135	molecular
T5	disease_or_phenotypic_feature 162 192	post-traumatic stress disorder
T6	disease_or_phenotypic_feature 194 198	PTSD
T7	disease_or_phenotypic_feature 266 273	obesity
T8	chemical 274 281	hormone
T9	chemical 282 288	leptin
T10	disease_or_phenotypic_feature 309 322	breast cancer
T11	chemical 333 343	Biomarkers
T12	disease_or_phenotypic_feature 359 365	injury
T13	disease_or_phenotypic_feature 370 383	renal failure
T14	chemical 401 412	cholesterol
T15	disease_or_phenotypic_feature 449 464	prostate cancer
T16	disease_or_phenotypic_feature 465 469	(PCa
T17	disease_or_phenotypic_feature 555 564	intrinsic
T18	chemical 676 686	cefotaxime
T19	chemical 738 751	enzyme-linked
T20	disease_or_phenotypic_feature 806 812	HS-RLS
T21	chemical 878 889	biochemical
T22	disease_or_phenotypic_feature 913 921	cataract
T23	chemical 964 972	antigens
T24	disease_or_phenotypic_feature 977 985	melanoma
T25	chemical 1086 1089	his
T26	disease_or_phenotypic_feature 1105 1114	condition
T27	disease_or_phenotypic_feature 1150 1157	abscess
T28	chemical 1275 1286	clindamycin
T29	disease_or_phenotypic_feature 1345 1356	hypotension
T30	chemical 1381 1386	group
T31	chemical 1525 1537	sex hormones
T32	disease_or_phenotypic_feature 1582 1595	breast cancer
T33	disease_or_phenotypic_feature 1606 1628	Oncogenic osteomalacia
T34	chemical 1704 1711	mineral
T35	disease_or_phenotypic_feature 1712 1736	metabolism abnormalities
T36	chemical 1742 1751	IGF1R/IRS
T37	disease_or_phenotypic_feature 1779 1807	acute lymphoblastic leukemia
T38	chemical 1857 1867	inhibitors
T39	chemical 1875 1884	IGF1R-IRS
T40	chemical 1888 1897	inhibitor
T41	chemical 1912 1920	IGF1R/IR
T42	chemical 1921 1930	inhibitor
T43	chemical 1976 1984	solution
T44	disease_or_phenotypic_feature 1989 1997	cataract
T45	disease_or_phenotypic_feature 2007 2023	Hyperinsulinemia
T46	chemical 2028 2037	oxidative
T47	chemical 2089 2102	anaesthetized
T48	chemical 2108 2116	propofol
T49	disease_or_phenotypic_feature 2121 2129	cataract
T50	chemical 2239 2247	proteins
T51	chemical 2268 2286	protease inhibitor
T52	disease_or_phenotypic_feature 2364 2370	cancer
T53	disease_or_phenotypic_feature 2392 2410	malignant melanoma
T54	disease_or_phenotypic_feature 2429 2432	TGA
T55	disease_or_phenotypic_feature 2445 2449	gave
T56	chemical 2520 2529	oxidation
T57	missed_chemical 901 912	naphthalene
R1	causes_or_contributes_to Arg1:T57 Arg2:T22	
T58	corrected_chemical 958 972	tumor antigens
R2	treats Arg1:T58 Arg2:T24	
T59	missed_chemical 1868 1873	NT157
R3	treats Arg1:T59 Arg2:T37	
T60	missed_disease_or_phenotypic_feature 1809 1812	ALL
R4	treats Arg1:T59 Arg2:T60	
T61	corrected_chemical 1875 1885;1888 1897	IGF1R-IRS1 inhibitor
T62	corrected_chemical 1875 1884;1886 1897	IGF1R-IRS 2 inhibitor
R5	treats Arg1:T62 Arg2:T60	
R6	treats Arg1:T61 Arg2:T37	
R7	treats Arg1:T62 Arg2:T37	
R8	treats Arg1:T61 Arg2:T60	
T63	corrected_chemical 1903 1910	OSI-906
R9	treats Arg1:T63 Arg2:T60	
R10	treats Arg1:T63 Arg2:T37	
T64	corrected_chemical 1912 1917;1921 1930	IGF1R inhibitor
T65	corrected_chemical 1918 1920;1921 1930	IR inhibitor
R11	treats Arg1:T65 Arg2:T37	
R12	treats Arg1:T65 Arg2:T60	
R13	treats Arg1:T64 Arg2:T60	
R14	treats Arg1:T64 Arg2:T37	
T66	corrected_disease_or_phenotypic_feature 2354 2370	prostrate cancer
T67	missed_disease_or_phenotypic_feature 2372 2387	oral carcinomas
T68	corrected_chemical 2256 2286	Bowman-Birk protease inhibitor
T69	missed_chemical 2291 2309	Mistletoe Lectin-I
R15	treats Arg1:T68 Arg2:T53	
R16	treats Arg1:T68 Arg2:T67	
R17	treats Arg1:T68 Arg2:T66	
R18	treats Arg1:T69 Arg2:T53	
R19	treats Arg1:T69 Arg2:T67	
R20	treats Arg1:T69 Arg2:T66	
T70	corrected_chemical 2223 2247	medicinal plant proteins
R21	treats Arg1:T70 Arg2:T53	
R22	treats Arg1:T70 Arg2:T67	
R23	treats Arg1:T70 Arg2:T66	
